FOMX
Bank of America’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-104,927
| Closed | -$349K | – | 6568 |
|
2019
Q4 | $349K | Buy |
104,927
+9,436
| +10% | +$31.4K | ﹤0.01% | 4517 |
|
2019
Q3 | $290K | Buy |
95,491
+40,059
| +72% | +$122K | ﹤0.01% | 4670 |
|
2019
Q2 | $132K | Buy |
55,432
+15,787
| +40% | +$37.6K | ﹤0.01% | 5097 |
|
2019
Q1 | $149K | Buy |
39,645
+28,730
| +263% | +$108K | ﹤0.01% | 4939 |
|
2018
Q4 | $39K | Sell |
10,915
-6,882
| -39% | -$24.6K | ﹤0.01% | 5537 |
|
2018
Q3 | $102K | Buy |
17,797
+13,886
| +355% | +$79.6K | ﹤0.01% | 5149 |
|
2018
Q2 | $20K | Sell |
3,911
-4,799
| -55% | -$24.5K | ﹤0.01% | 5767 |
|
2018
Q1 | $45K | Sell |
8,710
-10,917
| -56% | -$56.4K | ﹤0.01% | 5350 |
|
2017
Q4 | $118K | Buy |
19,627
+1,777
| +10% | +$10.7K | ﹤0.01% | 4898 |
|
2017
Q3 | $99K | Buy |
17,850
+7,734
| +76% | +$42.9K | ﹤0.01% | 4896 |
|
2017
Q2 | $47K | Buy |
10,116
+6,573
| +186% | +$30.5K | ﹤0.01% | 5148 |
|
2017
Q1 | $18K | Buy |
3,543
+25
| +0.7% | +$127 | ﹤0.01% | 5605 |
|
2016
Q4 | $39K | Buy |
3,518
+414
| +13% | +$4.59K | ﹤0.01% | 5270 |
|
2016
Q3 | $29K | Sell |
3,104
-9,277
| -75% | -$86.7K | ﹤0.01% | 5213 |
|
2016
Q2 | $79K | Buy |
+12,381
| New | +$79K | ﹤0.01% | 4859 |
|
2016
Q1 | – | Sell |
-5,452
| Closed | -$44K | – | 6355 |
|
2015
Q4 | $44K | Buy |
5,452
+5,372
| +6,715% | +$43.4K | ﹤0.01% | 5124 |
|
2015
Q3 | $1K | Sell |
80
-539
| -87% | -$6.74K | ﹤0.01% | 6019 |
|
2015
Q2 | $6K | Buy |
+619
| New | +$6K | ﹤0.01% | 5728 |
|